c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
DiaMedica Therapeutics (DMAC) Reports Key Clinical Milestones in Q3 2026, Eyes Q1 2027 DSMB Review
GuruFocus | Nov 13, 2026 2:57 PM EST
Related Stocks: DMAC ,
Read original article